Your gateway to a free society
Article

Biden versus Bastiat

Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Feb 15, 2026 /
Trump Says $5 Billion Pledged for Gaza Reconstruction, But Hamas Must Disarm
President Donald Trump announced that the Board of Peace had received $5 billion in donations for Gaza aid and reconstruction. The President also repeated his demand that Hamas disarm.  Trump wrote on Truth Social Sunday that the Board of Peace “will announce that Member States have pledged more than $5 BILLION DOLLARS toward the Gaza […]
Read more
Feb 13, 2026 / Tyler Durden
Stolen Land At The Grammys: How Hollywood Groupthink Threatens Democracy
Stolen Land At The Grammys: How Hollywood Groupthink Threatens Democracy Authored by Patrick Keeney via The Epoch Times (emphasis ours), Commentary Among the consolations of youth is the certainty with which one holds beliefs about the world. There is comfort in the conviction that one’s moral bearings are firmly set, that one’s understanding of complex questions is not only sincere but also correct. The world appears legible; right and wrong seem sharply drawn; doubt and nuance are dismissed as weakness or evasion. The 68th Grammy Awards Premiere Ceremony at Peacock Theater in Los...
Read more
Feb 23, 2026 / Tyler Durden
"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival
"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival Shares of Novo Nordisk A/S plummeted again on Monday after the company reported trial results showing its next-generation obesity shot, CagriSema, delivered 20.2% weight loss at 84 weeks, compared to 23.6% for Eli Lilly & Co.’s tirzepatide (Zepbound). Bloomberg Intelligence analyst Michael Shah explained, "This outcome is the worst-case scenario for Novo and heightens the need for M&A with Novo’s other GLP-1/Amylin drug." Shares of Novo in Copenhagen plunged as much as 16.5%, breaking below a support level...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.